|
1
|
Hajek C, Guo X, Yao J, Hai Y, Johnson WC,
Frazier-Wood AC, Post WS, Psaty BM, Taylor KD and Rotter JI:
Coronary heart disease genetic risk score predicts cardiovascular
disease risk in men, not women. Circ Genom Precis Med.
11(e002324)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Olubowale OT, Safford MM, Brown TM, Durant
RW, Howard VJ, Gamboa C, Glasser SP, Rhodes JD and Levitan EB:
Comparison of expert adjudicated coronary heart disease and
cardiovascular disease mortality with the national death index:
Results from the REasons for geographic and racial differences in
stroke (REGARDS) study. J Am Heart Assoc. 6(e004966)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yoshioka S, Tsukamoto T and Chihara K:
Vascular smooth muscle cells in coronary heart disease. Nihon
Rinsho. 61 (Suppl 4):S80–S85. 2003.PubMed/NCBI(In Japanese).
|
|
4
|
Wang S, Cheng Z and Chen X: Promotion of
PTEN on apoptosis through PI3K/Akt signal in vascular smooth muscle
cells of mice model of coronary heart disease. J Cell Biochem.
120:14636–14644. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lacolley P, Regnault V, Segers P and
Laurent S: Vascular smooth muscle cells and arterial stiffening:
Relevance in development, aging, and disease. Physiol Rev.
97:1555–1617. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Maier KG, Ruhle B, Stein JJ, Gentile KL,
Middleton FA and Gahtan V: Thrombospondin-1 differentially
regulates microRNAs in vascular smooth muscle cells. Mol Cell
Biochem. 412:111–117. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cheuk BL and Cheng SW: Identification and
characterization of microRNAs in vascular smooth muscle cells from
patients with abdominal aortic aneurysms. J Vasc Surg. 59:202–209.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Matuszcak C, Lindner K, Eichelmann AK,
Hussey DJ, Haier J and Hummel R: MicroRNAs: Key regulators of
chemotherapy response and metastatic potential via complex control
of target pathways in esophageal adenocarcinoma. Surg Oncol.
27:392–401. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pio G, Ceci M, D'Elia D, Loglisci C and
Malerba D: A novel biclustering algorithm for the discovery of
meaningful biological correlations between microRNAs and their
target genes. BMC Bioinformatics. 14 (Suppl 7)(S8)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
De Rosa S and Indolfi C: Circulating
microRNAs as biomarkers in cardiovascular diseases. Exp Suppl.
106:139–149. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fernandes T, Soci UP and Oliveira EM:
Eccentric and concentric cardiac hypertrophy induced by exercise
training: MicroRNAs and molecular determinants. Braz J Med Biol
Res. 44:836–847. 2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lin RC, Weeks KL, Gao XM, Williams RB,
Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD,
Mollica JP, et al: PI3K(p110 alpha) protects against myocardial
infarction-induced heart failure: Identification of PI3K-regulated
miRNA and mRNA. Arterioscler Thromb Vasc Biol. 30:724–732.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang H, Lu J, Wu S, Yang S, Wang L, Zhou
H, Fu Y and Liu J: Effects of electroacupuncture at different
acupoints on apoptosis and the expression of miRNAs in myocardial
cells in rats model of myocardial ischemia. Zhongguo Zhen Jiu.
36:281–286. 2016.PubMed/NCBI(In Chinese).
|
|
14
|
Seo HH, Lee SY, Lee CY, Kim R, Kim P, Oh
S, Lee H, Lee MY, Kim J, Kim LK, et al: Exogenous miRNA-146a
enhances the therapeutic efficacy of human mesenchymal stem cells
by increasing vascular endothelial growth factor secretion in the
ischemia/reperfusion-injured heart. J Vasc Res. 54:100–108.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu H, Xu L, Chen Y and Xu C: MiR-208a-3p
functions as an oncogene in colorectal cancer by targeting PDCD4.
Biosci Rep. 39(BSR20181598)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Montgomery RL, Hullinger TG, Semus HM,
Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN and
van Rooij E: Therapeutic inhibition of miR-208a improves cardiac
function and survival during heart failure. Circulation.
124:1537–1547. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cui HB, Ge HE, Wang YS and Bai XY:
MiR-208a enhances cell proliferation and invasion of gastric cancer
by targeting SFRP1 and negatively regulating MEG3. Int J Biochem
Cell Biol. 102:31–39. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hortmann M, Walter JE, Benning L, Follo M,
Mayr RM, Honegger U, Robinson S, Stallmann D, Duerschmied D,
Twerenbold R, et al: Droplet digital PCR of serum miR-499, miR-21
and miR-208a for the detection of functionally relevant coronary
artery disease. Int J Cardiol. 275:129–135. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhao S, Chen SR, Yang XF, Shen DF, Takano
Y, Su RJ and Zheng HC: BTG1 might be employed as a biomarker for
carcinogenesis and a target for gene therapy in colorectal cancers.
Oncotarget. 8:7502–7520. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wu ZW, Liu YF, Wang S and Li B: MiRNA-146a
induces vascular smooth muscle cell apoptosis in a rat model of
coronary heart disease via NF-kappaB pathway. Genet Mol Res.
14:18703–18712. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li FP, Lin DQ and Gao LY: LncRNA TUG1
promotes proliferation of vascular smooth muscle cell and
atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med
Pharmacol Sci. 22:7439–7447. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Afzal TA, Luong LA, Chen D, Zhang C, Yang
F, Chen Q, An W, Wilkes E, Yashiro K, Cutillas PR, et al: NCK
associated protein 1 modulated by miRNA-214 determines vascular
smooth muscle cell migration, proliferation, and neointima
hyperplasia. J Am Heart Assoc. 5(e004629)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li S, Jiang Z, Wen L, Feng G and Zhong G:
MicroRNA-208a-3p contributes to connexin40 remolding in human
chronic atrial fibrillation. Exp Ther Med. 14:5355–5362.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wang L, Ye N, Lian X, Peng F, Zhang H and
Gong H: MiR-208a-3p aggravates autophagy through the PDCD4-ATG5
pathway in Ang II-induced H9c2 cardiomyoblasts. Biomed
Pharmacother. 98:1–8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Glineur SF, De Ron P, Hanon E, Valentin
JP, Dremier S and Nogueira da Costa A: Paving the route to plasma
miR-208a-3p as an acute cardiac injury biomarker: Preclinical rat
data supports its use in drug safety assessment. Toxicol Sci.
149:89–97. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Huang Y, Zheng J, Tan T, Song L, Huang S,
Zhang Y, Lin L, Liu J, Zheng P, Chen X, et al: BTG1 low expression
in pancreatic ductal adenocarcinoma is associated with a poorer
prognosis. Int J Biol Markers. 33:189–194. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Su C, Huang DP, Liu JW, Liu WY and Cao YO:
MiR-27a-3p regulates proliferation and apoptosis of colon cancer
cells by potentially targeting BTG1. Oncol Lett. 18:2825–2834.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhao X, Chen GQ and Cao GM: Abnormal
expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 23:6888–6898. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014(150845)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Reddy D, Kumavath R, Tan TZ, Ampasala DR
and Kumar AP: Peruvoside targets apoptosis and autophagy through
MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human
cancers. Life Sci. 241(117147)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Feng H, Wang Z, Wang C, Zhu X, Liu Z, Liu
H, Guo M, Hou Q and Chu Z: Effect of furostanol saponins from
allium macrostemon bunge bulbs on platelet aggregation rate and
pi3k/akt pathway in the rat model of coronary heart disease. Evid
Based Complement Alternat Med. 2019(9107847)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jing R, Zhong QQ, Long TY, Pan W and Qian
ZX: Downregulated miRNA-26a-5p induces the apoptosis of endothelial
cells in coronary heart disease by inhibiting PI3K/AKT pathway. Eur
Rev Med Pharmacol Sci. 23:4940–4947. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chen X, Wang R, Chen W, Lai L and Li Z:
Decoy receptor-3 regulates inflammation and apoptosis via PI3K/AKT
signaling pathway in coronary heart disease. Exp Ther Med.
17:2614–2622. 2019.PubMed/NCBI View Article : Google Scholar
|
